The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Xiaolin Zhu; Yiping Zhang; Qingyu Luo; Xiaowei Wu; Furong Huang; Tong Shu; Yong Wan; Hongyan Chen; Zhihua Liu

doi:10.1038/s41392-021-00580-w

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Xiaolin Zhu, Yiping Zhang, Qingyu Luo, Xiaowei Wu, Furong Huang, Tong Shu, Yong Wan, Hongyan Chen^*, Zhihua Liu^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English (US)
Article number	264
Journal	Signal Transduction and Targeted Therapy
Volume	6
Issue number	1
DOIs	https://doi.org/10.1038/s41392-021-00580-w
State	Published - Dec 2021

Funding

This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).

ASJC Scopus subject areas

Genetics
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41392-021-00580-w

Cite this

@article{f8f9aacd2d4c43cd9bbc1b7b48a20b60,

title = "The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP",

author = "Xiaolin Zhu and Yiping Zhang and Qingyu Luo and Xiaowei Wu and Furong Huang and Tong Shu and Yong Wan and Hongyan Chen and Zhihua Liu",

note = "Funding Information: This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).",

year = "2021",

month = dec,

doi = "10.1038/s41392-021-00580-w",

language = "English (US)",

volume = "6",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

AU - Zhu, Xiaolin

AU - Zhang, Yiping

AU - Luo, Qingyu

AU - Wu, Xiaowei

AU - Huang, Furong

AU - Shu, Tong

AU - Wan, Yong

AU - Chen, Hongyan

AU - Liu, Zhihua

N1 - Funding Information: This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85110026417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110026417&partnerID=8YFLogxK

U2 - 10.1038/s41392-021-00580-w

DO - 10.1038/s41392-021-00580-w

M3 - Letter

C2 - 34257276

AN - SCOPUS:85110026417

SN - 2095-9907

VL - 6

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 264

ER -

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this